HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juan Sanchis Selected Research

Carbohydrates

4/2022Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
1/2022Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure.
1/2022Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction.
10/2021Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure.
6/2021CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.
1/2021Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
8/2020Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.
1/2020Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
1/2020CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
1/2018Cancer antigen-125 and outcomes in acute heart failure: a systematic review and meta-analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juan Sanchis Research Topics

Disease

90Heart Failure
12/2022 - 02/2002
29Myocardial Infarction
05/2022 - 12/2003
25Acute Coronary Syndrome
01/2021 - 08/2002
21Chest Pain (Chest Pains)
04/2021 - 02/2002
18Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2005
16ST Elevation Myocardial Infarction
01/2020 - 03/2008
15Infarction (Infarctions)
01/2021 - 08/2002
9Necrosis
09/2014 - 02/2005
7Thrombosis (Thrombus)
05/2022 - 03/2008
7Iron Deficiencies
05/2022 - 12/2016
7Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 09/2002
7Unstable Angina
12/2016 - 02/2002
6Hemorrhage
05/2022 - 08/2010
6Frailty
01/2020 - 12/2015
6Ischemia
01/2017 - 10/2002
5Inflammation (Inflammations)
01/2021 - 02/2005
4Death (Near-Death Experience)
05/2022 - 12/2003
4Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 09/2007
4Renal Insufficiency (Renal Failure)
01/2020 - 02/2017
4Atrial Fibrillation
08/2019 - 06/2015
4Stroke (Strokes)
06/2015 - 03/2008
4Pain (Aches)
10/2011 - 12/2003
3Non-ST Elevated Myocardial Infarction
01/2022 - 10/2016
3Type 2 Diabetes Mellitus (MODY)
12/2020 - 10/2015
3Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
08/2020 - 01/2020
3Hyperemia
12/2017 - 01/2012
2Acute Kidney Injury (Acute Renal Failure)
11/2020 - 03/2008
2Coronary Disease (Coronary Heart Disease)
01/2018 - 04/2005
2Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 09/2014
2Diabetes Mellitus
02/2017 - 03/2011
2Coronary Stenosis (Coronary Artery Stenosis)
09/2016 - 11/2009
2Hypertension (High Blood Pressure)
12/2014 - 01/2007
2Edema (Dropsy)
08/2013 - 08/2009
2Ventricular Tachycardia
03/2011 - 03/2011
2Ventricular Fibrillation
04/2008 - 11/2002
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2003 - 10/2003
1Mediastinal Fibrosis
11/2021

Drug/Important Bio-Agent (IBA)

28CarbohydratesIBA
04/2022 - 06/2007
25AntigensIBA
04/2022 - 06/2007
22Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2003
21TroponinIBA
04/2021 - 02/2003
11omega-Chloroacetophenone (Mace)IBA
11/2021 - 09/2007
9Brain Natriuretic Peptide (Natrecor)FDA Link
06/2021 - 12/2008
9Troponin IIBA
10/2006 - 02/2002
7C-Reactive ProteinIBA
05/2006 - 09/2003
6IronIBA
05/2022 - 12/2016
6pro-brain natriuretic peptide (1-76)IBA
01/2022 - 02/2010
6DiureticsIBA
01/2021 - 09/2012
6DobutamineFDA LinkGeneric
08/2013 - 11/2005
5Neprilysin (Neutral Endopeptidase)IBA
12/2022 - 08/2015
5HomocysteineIBA
01/2021 - 09/2003
5Fibrinogen (Factor I)FDA Link
02/2005 - 08/2002
4ferric carboxymaltoseIBA
01/2022 - 06/2018
4SodiumIBA
07/2021 - 04/2018
4Troponin T (Troponin T1)IBA
04/2021 - 08/2012
4Glycoproteins (Glycoprotein)IBA
01/2021 - 10/2013
4trans-crotonin (CTN)IBA
09/2020 - 10/2014
4CreatinineIBA
08/2017 - 04/2005
4Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
07/2014 - 05/2012
3Insulin (Novolin)FDA Link
12/2020 - 10/2015
3Glucose (Dextrose)FDA LinkGeneric
04/2018 - 03/2011
3P-2 (P 2)IBA
10/2015 - 02/2010
3Tumor Biomarkers (Tumor Markers)IBA
09/2014 - 10/2010
3Dipyridamole (Persantine)FDA LinkGeneric
09/2014 - 09/2007
3thioflavin TIBA
07/2014 - 09/2010
3Platelet Membrane GlycoproteinsIBA
11/2013 - 09/2010
3Acute-Phase Proteins (Acute-Phase Protein)IBA
04/2005 - 08/2002
3MyoglobinIBA
02/2005 - 02/2003
2EverolimusFDA Link
05/2022 - 09/2010
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2020
2Oxygen (Dioxygen)IBA
02/2021 - 04/2018
2HydrogenIBA
01/2021 - 05/2019
2empagliflozinIBA
12/2020 - 04/2018
2sacubitril and valsartan sodium hydrate drug combinationIBA
12/2020 - 01/2019
2Vitamin KFDA Link
08/2019 - 03/2016
2Indicators and Reagents (Reagents)IBA
01/2019 - 12/2003
2PotassiumIBA
10/2018 - 01/2018
2AnticoagulantsIBA
03/2016 - 06/2015
2ProcalcitoninIBA
01/2015 - 12/2014
2CytokinesIBA
09/2014 - 08/2010
2GadoliniumIBA
07/2014 - 01/2012
2Clopidogrel (Plavix)FDA Link
11/2013 - 10/2013
2triphenyltetrazoliumIBA
11/2013 - 09/2010
2Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2009 - 10/2009
1Angiotensin Receptors (Angiotensin II Receptor)IBA
12/2022
1dapagliflozinIBA
10/2022
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
05/2022
1Vasodilator Agents (Vasodilators)IBA
12/2021
1Immunoglobulin G (IgG)IBA
11/2021

Therapy/Procedure

14Therapeutics
03/2021 - 11/2009
12Patient Readmission
01/2020 - 03/2006
10Percutaneous Coronary Intervention
01/2020 - 09/2010
6Stents
05/2022 - 03/2008
5Drug-Eluting Stents
07/2018 - 03/2008
4Length of Stay
10/2021 - 09/2002
3Catheters
11/2020 - 08/2010
2Transcatheter Aortic Valve Replacement
11/2021 - 05/2013
2Continuous Ambulatory Peritoneal Dialysis (CAPD)
11/2012 - 05/2012
2Secondary Prevention
01/2010 - 02/2008
2Electrodes (Electrode)
04/2008 - 11/2002